Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 241 entries
Sorted by: Best Match Show Resources per page
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care.

Journal of the Canadian Association of Gastroenterology

Jones JL, Benchimol EI, Bernstein CN, Huang JG, Marshall JK, Mukhtar MS, Murthy SK, Nguyen GC, Kaplan GG, Kuenzig ME, Tandon P, Targownik LE, Windsor JW, Bitton A.
PMID: 34755041
J Can Assoc Gastroenterol. 2021 Oct 26;4:S61-S67. doi: 10.1093/jcag/gwab034. eCollection 2021 Dec.

The SARS-CoV-2 pandemic has had a profound impact on inflammatory bowel disease (IBD) health care delivery. The implementation of necessary public health restrictions has restricted access to medications, procedures and surgeries throughout the pandemic, catalyzing widespread change in how...

Cite
Jones JL, Benchimol EI, Bernstein CN, et al. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care. J Can Assoc Gastroenterol. 2021;4:S61-S67doi: 10.1093/jcag/gwab034.
Jones, J. L., Benchimol, E. I., Bernstein, C. N., Huang, J. G., Marshall, J. K., Mukhtar, M. S., Murthy, S. K., Nguyen, G. C., Kaplan, G. G., Kuenzig, M. E., Tandon, P., Targownik, L. E., Windsor, J. W., & Bitton, A. (2021). Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care. Journal of the Canadian Association of Gastroenterology, 4S61-S67. https://doi.org/10.1093/jcag/gwab034
Jones, Jennifer L, et al. "Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care." Journal of the Canadian Association of Gastroenterology vol. 4 (2021): S61-S67. doi: https://doi.org/10.1093/jcag/gwab034
Jones JL, Benchimol EI, Bernstein CN, Huang JG, Marshall JK, Mukhtar MS, Murthy SK, Nguyen GC, Kaplan GG, Kuenzig ME, Tandon P, Targownik LE, Windsor JW, Bitton A. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care. J Can Assoc Gastroenterol. 2021 Oct 26;4:S61-S67. doi: 10.1093/jcag/gwab034. eCollection 2021 Dec. PMID: 34755041; PMCID: PMC8570426.
Copy Download .nbib Format: NLM
Potential Benefit of Add-on Δ9-Tetrahydrocannabinol in Pediatric Drug-Resistant Epilepsy: A Case Series.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Nowicki M, Bourgeois-Tardif S, Diaz PL, Hebert FO, Sanon NT, Champagne PO, Major P, Sell E, Bitton J, Lewis E, Weil AG.
PMID: 34183079
Can J Neurol Sci. 2021 Jun 29;1-3. doi: 10.1017/cjn.2021.151. Epub 2021 Jun 29.

We present five cases of pediatric drug-resistant epilepsy (DRE) that failed management using high cannabidiol (CBD) doses, but had significant reduction in seizure frequency with reintroduction or increasing doses of tetrahydrocannabinol (THC). There is growing evidence supporting the use...

Cite
Nowicki M, Bourgeois-Tardif S, Diaz PL, et al. Potential Benefit of Add-on Δ9-Tetrahydrocannabinol in Pediatric Drug-Resistant Epilepsy: A Case Series. Can J Neurol Sci. 2021;1-3doi: 10.1017/cjn.2021.151.
Nowicki, M., Bourgeois-Tardif, S., Diaz, P. L., Hebert, F. O., Sanon, N. T., Champagne, P. O., Major, P., Sell, E., Bitton, J., Lewis, E., & Weil, A. G. (2021). Potential Benefit of Add-on Δ9-Tetrahydrocannabinol in Pediatric Drug-Resistant Epilepsy: A Case Series. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1-3. https://doi.org/10.1017/cjn.2021.151
Nowicki, Magda, et al. "Potential Benefit of Add-on Δ9-Tetrahydrocannabinol in Pediatric Drug-Resistant Epilepsy: A Case Series." The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques vol. (2021): 1-3. doi: https://doi.org/10.1017/cjn.2021.151
Nowicki M, Bourgeois-Tardif S, Diaz PL, Hebert FO, Sanon NT, Champagne PO, Major P, Sell E, Bitton J, Lewis E, Weil AG. Potential Benefit of Add-on Δ9-Tetrahydrocannabinol in Pediatric Drug-Resistant Epilepsy: A Case Series. Can J Neurol Sci. 2021 Jun 29;1-3. doi: 10.1017/cjn.2021.151. Epub 2021 Jun 29. PMID: 34183079.
Copy Download .nbib Format: NLM
Preexposure Prophylaxis for Women Across the Criminal Justice System: Implications for Policy and Practice.

Journal of correctional health care : the official journal of the National Commission on Correctional Health Care

Hoff E, Rutledge R, Gibson BA, Price CR, Gallagher C, Maurer K, Meyer JP.
PMID: 34762498
J Correct Health Care. 2021 Nov 11; doi: 10.1089/jchc.19.11.0082. Epub 2021 Nov 11.

Data that inform preexposure prophylaxis (PrEP) implementation for women involved in criminal justice (WICJ) systems are scarce. In a survey of PrEP attitudes, acceptability, and barriers across the criminal justice system, incarcerated women (

Cite
Hoff E, Rutledge R, Gibson BA, et al. Preexposure Prophylaxis for Women Across the Criminal Justice System: Implications for Policy and Practice. J Correct Health Care. 2021;doi: 10.1089/jchc.19.11.0082.
Hoff, E., Rutledge, R., Gibson, B. A., Price, C. R., Gallagher, C., Maurer, K., & Meyer, J. P. (2021). Preexposure Prophylaxis for Women Across the Criminal Justice System: Implications for Policy and Practice. Journal of correctional health care : the official journal of the National Commission on Correctional Health Care, . https://doi.org/10.1089/jchc.19.11.0082
Hoff, Emily, et al. "Preexposure Prophylaxis for Women Across the Criminal Justice System: Implications for Policy and Practice." Journal of correctional health care : the official journal of the National Commission on Correctional Health Care vol. (2021). doi: https://doi.org/10.1089/jchc.19.11.0082
Hoff E, Rutledge R, Gibson BA, Price CR, Gallagher C, Maurer K, Meyer JP. Preexposure Prophylaxis for Women Across the Criminal Justice System: Implications for Policy and Practice. J Correct Health Care. 2021 Nov 11; doi: 10.1089/jchc.19.11.0082. Epub 2021 Nov 11. PMID: 34762498.
Copy Download .nbib Format: NLM
Surfactant-Mediated Co-Existence of Single-Walled Carbon Nanotube Networks and Cellulose Nanocrystal Mesophases.

Nanomaterials (Basel, Switzerland)

Attia D, Yekymov E, Shmidov Y, Levi-Kalisman Y, Mendelson O, Bitton R, Yerushalmi-Rozen R.
PMID: 34835823
Nanomaterials (Basel). 2021 Nov 13;11(11). doi: 10.3390/nano11113059.

Hybrids comprising cellulose nanocrystals (CNCs) and percolated networks of single-walled carbon nanotubes (SWNTs) may serve for the casting of hybrid materials with improved optical, mechanical, electrical, and thermal properties. However, CNC-dispersed SWNTs are depleted from the chiral nematic (

Cite
Attia D, Yekymov E, Shmidov Y, et al. Surfactant-Mediated Co-Existence of Single-Walled Carbon Nanotube Networks and Cellulose Nanocrystal Mesophases. Nanomaterials (Basel). 2021;11(11)doi: 10.3390/nano11113059.
Attia, D., Yekymov, E., Shmidov, Y., Levi-Kalisman, Y., Mendelson, O., Bitton, R., & Yerushalmi-Rozen, R. (2021). Surfactant-Mediated Co-Existence of Single-Walled Carbon Nanotube Networks and Cellulose Nanocrystal Mesophases. Nanomaterials (Basel, Switzerland), 11(11), . https://doi.org/10.3390/nano11113059
Attia, David, et al. "Surfactant-Mediated Co-Existence of Single-Walled Carbon Nanotube Networks and Cellulose Nanocrystal Mesophases." Nanomaterials (Basel, Switzerland) vol. 11,11 (2021). doi: https://doi.org/10.3390/nano11113059
Attia D, Yekymov E, Shmidov Y, Levi-Kalisman Y, Mendelson O, Bitton R, Yerushalmi-Rozen R. Surfactant-Mediated Co-Existence of Single-Walled Carbon Nanotube Networks and Cellulose Nanocrystal Mesophases. Nanomaterials (Basel). 2021 Nov 13;11(11). doi: 10.3390/nano11113059. PMID: 34835823; PMCID: PMC8624387.
Copy Download .nbib Format: NLM
Pharmacokinetic-based failure of a detergent virucidal for SARS-COV-2 nasal infections.

Research square

Esther CR, Kimura KS, Mikami Y, Edwards CE, Das SR, Freeman MH, Strickland BA, Brown HM, Wessinger BC, Gupta VC, Von Wahlde K, Sheng Q, Huang LC, Bacon DR, Kimple AJ, Ceppe AS, Kato T, Pickles RJ, Randell SH, Baric RS, Turner JH, Boucher RC.
PMID: 34013253
Res Sq. 2021 May 14; doi: 10.21203/rs.3.rs-500168/v1.

The nose is the portal for SARS-CoV-2 infection, suggesting the nose as a target for topical antiviral therapies. Because detergents are virucidal, Johnson and Johnson's Baby Shampoo (J&J) was tested as a topical virucidal agent in SARS-CoV-2 infected subjects....

Cite
Esther CR, Kimura KS, Mikami Y, et al. Pharmacokinetic-based failure of a detergent virucidal for SARS-COV-2 nasal infections. Res Sq. 2021;doi: 10.21203/rs.3.rs-500168/v1.
Esther, C. R., Kimura, K. S., Mikami, Y., Edwards, C. E., Das, S. R., Freeman, M. H., Strickland, B. A., Brown, H. M., Wessinger, B. C., Gupta, V. C., Von Wahlde, K., Sheng, Q., Huang, L. C., Bacon, D. R., Kimple, A. J., Ceppe, A. S., Kato, T., Pickles, R. J., Randell, S. H., Baric, R. S., Turner, J. H., & Boucher, R. C. (2021). Pharmacokinetic-based failure of a detergent virucidal for SARS-COV-2 nasal infections. Research square, . https://doi.org/10.21203/rs.3.rs-500168/v1
Esther, Charles R, et al. "Pharmacokinetic-based failure of a detergent virucidal for SARS-COV-2 nasal infections." Research square vol. (2021). doi: https://doi.org/10.21203/rs.3.rs-500168/v1
Esther CR, Kimura KS, Mikami Y, Edwards CE, Das SR, Freeman MH, Strickland BA, Brown HM, Wessinger BC, Gupta VC, Von Wahlde K, Sheng Q, Huang LC, Bacon DR, Kimple AJ, Ceppe AS, Kato T, Pickles RJ, Randell SH, Baric RS, Turner JH, Boucher RC. Pharmacokinetic-based failure of a detergent virucidal for SARS-COV-2 nasal infections. Res Sq. 2021 May 14; doi: 10.21203/rs.3.rs-500168/v1. PMID: 34013253; PMCID: PMC8132247.
Copy Download .nbib Format: NLM
Fucosyltransferase 2 Mutations Are Associated With a Favorable Clinical Course in Crohn's Disease.

Journal of clinical gastroenterology

Battat R, Qatomah A, Kopylov U, Wyse J, Cohen A, Afif W, Lakatos PL, Seidman E, Bitton A, Bessissow T.
PMID: 34739405
J Clin Gastroenterol. 2021 Nov 04; doi: 10.1097/MCG.0000000000001626. Epub 2021 Nov 04.

BACKGROUND: Fucosyltransferase 2 (FUT2) participates in intestinal antigen secretion and bacterial adherence. FUT2 homozygous nonsense mutations (FUT2M) and subsequent nonsecretor status is associated with Crohn's disease (CD). The common null allele is rs601338. We assessed the relationship between FUT2M...

Cite
Battat R, Qatomah A, Kopylov U, et al. Fucosyltransferase 2 Mutations Are Associated With a Favorable Clinical Course in Crohn's Disease. J Clin Gastroenterol. 2021;doi: 10.1097/MCG.0000000000001626.
Battat, R., Qatomah, A., Kopylov, U., Wyse, J., Cohen, A., Afif, W., Lakatos, P. L., Seidman, E., Bitton, A., & Bessissow, T. (2021). Fucosyltransferase 2 Mutations Are Associated With a Favorable Clinical Course in Crohn's Disease. Journal of clinical gastroenterology, . https://doi.org/10.1097/MCG.0000000000001626
Battat, Robert, et al. "Fucosyltransferase 2 Mutations Are Associated With a Favorable Clinical Course in Crohn's Disease." Journal of clinical gastroenterology vol. (2021). doi: https://doi.org/10.1097/MCG.0000000000001626
Battat R, Qatomah A, Kopylov U, Wyse J, Cohen A, Afif W, Lakatos PL, Seidman E, Bitton A, Bessissow T. Fucosyltransferase 2 Mutations Are Associated With a Favorable Clinical Course in Crohn's Disease. J Clin Gastroenterol. 2021 Nov 04; doi: 10.1097/MCG.0000000000001626. Epub 2021 Nov 04. PMID: 34739405.
Copy Download .nbib Format: NLM
Temperament and eating self-regulation in young children with or at risk for obesity: An exploratory report.

Pediatric obesity

Button A, Faith MS, Berkowitz RI.
PMID: 34080805
Pediatr Obes. 2021 Nov;16(11):e12821. doi: 10.1111/ijpo.12821. Epub 2021 Jun 02.

BACKGROUND: Few studies have examined the relationship between temperament and eating self-regulation in early childhood, despite emerging evidence for associations with pediatric obesity.METHOD: The aim of this exploratory report was to examine the associations between three eating behaviors and...

Cite
Button A, Faith MS, Berkowitz RI. Temperament and eating self-regulation in young children with or at risk for obesity: An exploratory report. Pediatr Obes. 2021;16(11):e12821doi: 10.1111/ijpo.12821.
Button, A., Faith, M. S., & Berkowitz, R. I. (2021). Temperament and eating self-regulation in young children with or at risk for obesity: An exploratory report. Pediatric obesity, 16(11), e12821. https://doi.org/10.1111/ijpo.12821
Button, Alyssa, et al. "Temperament and eating self-regulation in young children with or at risk for obesity: An exploratory report." Pediatric obesity vol. 16,11 (2021): e12821. doi: https://doi.org/10.1111/ijpo.12821
Button A, Faith MS, Berkowitz RI. Temperament and eating self-regulation in young children with or at risk for obesity: An exploratory report. Pediatr Obes. 2021 Nov;16(11):e12821. doi: 10.1111/ijpo.12821. Epub 2021 Jun 02. PMID: 34080805.
Copy Download .nbib Format: NLM
Complex nanoemulsion for vitamin delivery: droplet organization and interaction with skin membranes.

Nanoscale

Machado N, Bruininks BMH, Singh P, Dos Santos L, Dal Pizzol C, Dieamant GC, Kruger O, Martin AA, Marrink SJ, Souza PCT, Favero PP.
PMID: 34913938
Nanoscale. 2021 Dec 16; doi: 10.1039/d1nr04610a. Epub 2021 Dec 16.

Lipid nanoemulsions are promising nanomaterials for drug delivery applications in food, pharmaceutical and cosmetic industries. Despite the noteworthy commercial interest, little is known about their supramolecular organization, especially about how such multicomponent formulations interact with cell membranes. In the...

Cite
Machado N, Bruininks BMH, Singh P, et al. Complex nanoemulsion for vitamin delivery: droplet organization and interaction with skin membranes. Nanoscale. 2021;doi: 10.1039/d1nr04610a.
Machado, N., Bruininks, B. M. H., Singh, P., Dos Santos, L., Dal Pizzol, C., Dieamant, G. C., Kruger, O., Martin, A. A., Marrink, S. J., Souza, P. C. T., & Favero, P. P. (2021). Complex nanoemulsion for vitamin delivery: droplet organization and interaction with skin membranes. Nanoscale, . https://doi.org/10.1039/d1nr04610a
Machado, Neila, et al. "Complex nanoemulsion for vitamin delivery: droplet organization and interaction with skin membranes." Nanoscale vol. (2021). doi: https://doi.org/10.1039/d1nr04610a
Machado N, Bruininks BMH, Singh P, Dos Santos L, Dal Pizzol C, Dieamant GC, Kruger O, Martin AA, Marrink SJ, Souza PCT, Favero PP. Complex nanoemulsion for vitamin delivery: droplet organization and interaction with skin membranes. Nanoscale. 2021 Dec 16; doi: 10.1039/d1nr04610a. Epub 2021 Dec 16. PMID: 34913938.
Copy Download .nbib Format: NLM
Microbial community structure and composition is associated with host species and sex in Sigmodon cotton rats.

Animal microbiome

Strickland BA, Patel MC, Shilts MH, Boone HH, Kamali A, Zhang W, Stylos D, Boukhvalova MS, Rosas-Salazar C, Yooseph S, Rajagopala SV, Blanco JCG, Das SR.
PMID: 33863395
Anim Microbiome. 2021 Apr 16;3(1):29. doi: 10.1186/s42523-021-00090-8.

BACKGROUND: The cotton rat (genus Sigmodon) is an essential small animal model for the study of human infectious disease and viral therapeutic development. However, the impact of the host microbiome on infection outcomes has not been explored in this...

Cite
Strickland BA, Patel MC, Shilts MH, et al. Microbial community structure and composition is associated with host species and sex in Sigmodon cotton rats. Anim Microbiome. 2021;3(1):29doi: 10.1186/s42523-021-00090-8.
Strickland, B. A., Patel, M. C., Shilts, M. H., Boone, H. H., Kamali, A., Zhang, W., Stylos, D., Boukhvalova, M. S., Rosas-Salazar, C., Yooseph, S., Rajagopala, S. V., Blanco, J. C. G., & Das, S. R. (2021). Microbial community structure and composition is associated with host species and sex in Sigmodon cotton rats. Animal microbiome, 3(1), 29. https://doi.org/10.1186/s42523-021-00090-8
Strickland, Britton A, et al. "Microbial community structure and composition is associated with host species and sex in Sigmodon cotton rats." Animal microbiome vol. 3,1 (2021): 29. doi: https://doi.org/10.1186/s42523-021-00090-8
Strickland BA, Patel MC, Shilts MH, Boone HH, Kamali A, Zhang W, Stylos D, Boukhvalova MS, Rosas-Salazar C, Yooseph S, Rajagopala SV, Blanco JCG, Das SR. Microbial community structure and composition is associated with host species and sex in Sigmodon cotton rats. Anim Microbiome. 2021 Apr 16;3(1):29. doi: 10.1186/s42523-021-00090-8. PMID: 33863395; PMCID: PMC8051552.
Copy Download .nbib Format: NLM
What kind of evidence do we need to strengthen primary healthcare in the 21st century?.

BMJ global health

Hirschhorn LR, Langlois EV, Bitton A, Ghaffar A.
PMID: 31478031
BMJ Glob Health. 2019 Aug 16;4:e001668. doi: 10.1136/bmjgh-2019-001668. eCollection 2019.

No abstract available.

Cite
Hirschhorn LR, Langlois EV, Bitton A, et al. What kind of evidence do we need to strengthen primary healthcare in the 21st century?. BMJ Glob Health. 2019;4:e001668doi: 10.1136/bmjgh-2019-001668.
Hirschhorn, L. R., Langlois, E. V., Bitton, A., & Ghaffar, A. (2019). What kind of evidence do we need to strengthen primary healthcare in the 21st century?. BMJ global health, 4e001668. https://doi.org/10.1136/bmjgh-2019-001668
Hirschhorn, Lisa R, et al. "What kind of evidence do we need to strengthen primary healthcare in the 21st century?." BMJ global health vol. 4 (2019): e001668. doi: https://doi.org/10.1136/bmjgh-2019-001668
Hirschhorn LR, Langlois EV, Bitton A, Ghaffar A. What kind of evidence do we need to strengthen primary healthcare in the 21st century?. BMJ Glob Health. 2019 Aug 16;4:e001668. doi: 10.1136/bmjgh-2019-001668. eCollection 2019. PMID: 31478031; PMCID: PMC6703285.
Copy Download .nbib Format: NLM
Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive Summary.

Journal of the Canadian Association of Gastroenterology

Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J.
PMID: 31616855
J Can Assoc Gastroenterol. 2019 Dec;2(4):149-152. doi: 10.1093/jcag/gwy069. Epub 2019 Feb 01.

The use of immunosuppressive therapies for immune-mediated disease (IMD) is associated with an elevated risk of infections and related comorbidities. While many infectious diseases can generally be prevented by vaccines, immunization rates in this specific patient population remain suboptimal,...

Cite
Papp KA, Haraoui B, Kumar D, et al. Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive Summary. J Can Assoc Gastroenterol. 2019;2(4):149-152doi: 10.1093/jcag/gwy069.
Papp, K. A., Haraoui, B., Kumar, D., Marshall, J. K., Bissonnette, R., Bitton, A., Bressler, B., Gooderham, M., Ho, V., Jamal, S., Pope, J. E., Steinhart, A. H., Vinh, D. C., & Wade, J. (2019). Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive Summary. Journal of the Canadian Association of Gastroenterology, 2(4), 149-152. https://doi.org/10.1093/jcag/gwy069
Papp, Kim A, et al. "Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive Summary." Journal of the Canadian Association of Gastroenterology vol. 2,4 (2019): 149-152. doi: https://doi.org/10.1093/jcag/gwy069
Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J. Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive Summary. J Can Assoc Gastroenterol. 2019 Dec;2(4):149-152. doi: 10.1093/jcag/gwy069. Epub 2019 Feb 01. PMID: 31616855; PMCID: PMC6785689.
Copy Download .nbib Format: NLM
Erratum: A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?.

Inflammatory bowel diseases

Marcil V, Levy E, Amre D, Bitton A, Sant'Anna AMGA, Szilagy A, Sinnett D, Seidman EG.
PMID: 31746991
Inflamm Bowel Dis. 2020 Jan 01;26(1):160. doi: 10.1093/ibd/izz275.

No abstract available.

Cite
Marcil V, Levy E, Amre D, et al. Erratum: A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?. Inflamm Bowel Dis. 2020;26(1):160doi: 10.1093/ibd/izz275.
Marcil, V., Levy, E., Amre, D., Bitton, A., Sant'Anna, A. M. G. A., Szilagy, A., Sinnett, D., & Seidman, E. G. (2020). Erratum: A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?. Inflammatory bowel diseases, 26(1), 160. https://doi.org/10.1093/ibd/izz275
Marcil, Valérie, et al. "Erratum: A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?." Inflammatory bowel diseases vol. 26,1 (2020): 160. doi: https://doi.org/10.1093/ibd/izz275
Marcil V, Levy E, Amre D, Bitton A, Sant'Anna AMGA, Szilagy A, Sinnett D, Seidman EG. Erratum: A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?. Inflamm Bowel Dis. 2020 Jan 01;26(1):160. doi: 10.1093/ibd/izz275. PMID: 31746991; PMCID: PMC7185688.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 241 entries